 SAVE THE DATE - Pride Toronto 2023 will be held on June 23, 24 & 25.
|
|
|
|
CONFERENCE ANNOUNCEMENT
Adherence 2023 will take place June 11-13, 2023, in Puerto Rico.
This 18th in an annual series of IAPAC conferences is dedicated to the presentation and discussion of HIV treatment and biomedical prevention adherence within the context of optimizing HIV prevention and treatment continua.
The conference will feature a keynote address, memorial lecture, memorial colloquium, four thematic sessions, oral abstract sessions (including late-breakers), and e-poster sessions. The conference program will reflect four tracks: HIV Care Continuum; Implementation Science; Optimizing ART Adherence; and PrEP Uptake, Adherence, and Persistence.
|
|
|
|
|
Abstracts topics fall under CAHR's four tracks: Basic Sciences; Clinical Sciences; Epidemiology and Public Health Sciences; and Social Sciences. In addition, authors can select whether they want to be considered for presentation in a Key Populations focused session. Visit the Abstract Submission page of the Conference website for a list of all subjects as well as full submission guidelines.
The submission deadline is Wednesday, January 11, 2023. |
|
|
|
|
HIV Treatment has come a long way. The landscape of HIV treatment brings with it new technological advancements, including dual-drug therapies and longer acting injectables.
This webinar aims to improve knowledge of long-acting injectable HIV treatment options among all service providers working with people living with HIV in Ontario, including clinicians, pharmacists and community-based workers. Attendees will have the opportunity to learn from people living with HIV, lived experience as well as from provider perspectives to understand clinical considerations, eligibility, and HIV treatment access for communities they serve. Additionally, participants will have the opportunity to think through considerations for reaching marginalized people and communities who could benefit from long-acting injectable HIV treatment through a lens of HIV-related health equity.
Learning Objectives
- Learn what injectable treatment is, and how it fits into the landscape of HIV treatment options
- Learn considerations for injectable treatment
- From a combination of living experience and provider perspectives, learn how best to support people in understanding, considering and accessing treatment options
- Explore how to ensure pathways to HIV treatment, including injectable treatment, are provided through a lens of cultural humility and foster medical trust
Audience:
People living with HIV and Ontario service providers (clinicians, pharmacists) and community-based workers.
This is a virtual webinar.
Presenters:
- Dr. Johnathan Angel MD FRCPC, Ottawa General Hospital
- Albert Beck IPHA, Director Manitoba Metis Federation, Ottawa Ontario
December 14, 2022 - 1:00 to 4:00 p
Register Here
|
|
|
Connecting to Mental Health Care
When: December 15th, 2022 @ 1-3pm EST
Description:
This virtual meeting is for any clinical and non-clinical workers supporting people living with HIV, to learn what mental health services exist, and how to refer your clients.
Audience:
This session is intended for clinical and non-clinical workers supporting people living with HIV.
This includes: HIV Mental Health workers in ASOs and clinical environments, front line support workers, and private practitioners serving HIV positive clients
Attendees do not need to be members of the HIV Mental Health Network.
Register Here
|
|
|
|
The Government of Canada opened its online consultations on HIV criminalization and law reform on October 20.
“HIV non-disclosure” refers to criminal cases where a person living with HIV, who is aware of their status and knows they are infectious, does not disclose their HIV status before sexual activity that poses a realistic possibility of transmission.
Participants are invited to share their views on possible criminal law reforms related to HIV non-disclosure.
As part of the consultation, areas to be explored include:
- Whether sexual assault offences are appropriate in HIV non-disclosure cases;
- Whether intention to transmit or actual transmission should be requirements for criminal charges to be laid;
- Whether criminal law should apply in cases where an accused has taken precautions to protect their sexual partner(s) from transmission;
- Whether a new HIV, STI or infectious disease-specific offence should be created to address HIV non-disclosure cases.
|
|
Flu, Respiratory & COVID-19 Resources
|
|
|
|
|
|
